SCHEMBL21995210

SCHEMBL21995210

Cc1ccc(S(=O)(=O)CC#N)c(C(F)(F)F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 1/20 0.43
FFAR4 Q5NUL3 1/20 0.38
ALDH1A1 P00352 2/20 0.38
LMNA P02545 1/20 0.38
PKM P14618 1/20 0.38
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
AR P10275 7/20 0.38
CNR2 P34972 1/20 0.36
GLA P06280 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
ATM Q13315 1/20 0.35
PLA2G7 Q13093 1/20 0.34
SLC22A12 Q96S37 3/20 0.34
CYP2C19 P33261 1/20 0.34
ABCB11 O95342 1/20 0.34
ALB P02768 1/20 0.34
PGR P06401 1/20 0.34
ADRA2C P18825 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31514065 1.00 TRPV4 (0.43) TRPV4FFAR4ALDH1A1LMNAPKM
SCHEMBL17376428 0.80 KAT6A (0.38) LMNAKMT2AGLAHPGD
SCHEMBL21995249 0.79 MEP1B (0.42) ALDH1A1LMNAKMT2AGLAGAA
SCHEMBL30773057 0.79 MEP1B (0.42) ALDH1A1LMNAKMT2AGLAGAA
SCHEMBL29250332 0.78 SLC22A12 (0.52) ALDH1A1KMT2ASLC22A12
SCHEMBL22056787 0.76 GABRA1 (0.37) TRPV4ALDH1A1PKMGLAGAA
SCHEMBL22057011 0.76 GLA (0.36) ALDH1A1LMNAKMT2AGLACYP2C19
SCHEMBL12879058 0.75 PIK3CD (0.44) TRPV4FFAR4KMT2ACYP2C19ABCB11
SCHEMBL31514048 0.74 MCOLN3 (0.48) TRPV4ALDH1A1LMNAPKMHTT
SCHEMBL21994820 0.74 MCOLN3 (0.48) TRPV4ALDH1A1LMNAPKMHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509462-B2 3-(phenylsulfonyl)-[1,2,3]triazolo[1,5A]quinazolin-5(4H)-one derivatives BioVersys AG (CH) 2025-12-30 US disclosed
EP-3887375-B1 3-(PHENYLSULFONYL)-[1,2,3]TRIAZOLO[1,5A]QUINAZOLIN-5(4H)-ONE DERIVATIVES BioVersys AG (CH) 2024-11-20 EP disclosed
US-20220024928-A1 3-(PHENYLSULFONYL)-[1,2,3]TRIAZOLO[1,5A]QUINAZOLIN-5(4H)-ONE DERIVATIVES BioVersys AG (CH) 2022-01-27 US disclosed
US-20220024928-A1 3-(PHENYLSULFONYL)-[1,2,3]TRIAZOLO[1,5A]QUINAZOLIN-5(4H)-ONE DERIVATIVES BioVersys AG (CH) 2022-01-27 US disclosed
EP-3887375-A1 3-(PHENYLSULFONYL)-[1,2,3]TRIAZOLO[1,5A]QUINAZOLIN-5(4H)-ONE DERIVATIVES Bioversys AG (CH) 2021-10-06 EP disclosed
CN-113195493-A 3- (benzenesulfonyl) - [1,2,3] triazolo [1,5a ] quinazolin-5 (4H) -one derivatives 生物验证系统股份公司 2021-07-30 CN disclosed
WO-2020109350-A1 3-(PHENYLSULFONYL)-[1,2,3]TRIAZOLO[1,5A]QUINAZOLIN-5(4H)-ONE DERIVATIVES BioVersys AG (CH) 2020-06-04 WO disclosed
WO-2020109350-A1 3-(PHENYLSULFONYL)-[1,2,3]TRIAZOLO[1,5A]QUINAZOLIN-5(4H)-ONE DERIVATIVES BioVersys AG (CH) 2020-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220024928-A1 3-(PHENYLSULFONYL)-[1,2,3]TRIAZOLO[1,5A]QUINAZOLIN-5(4H)-ONE DERIVATIVES OR10J3, ORC3, CBR3 TRPV4 1487/4885FFAR4 2997/4885ALDH1A1 1547/4885
US-12509462-B2 3-(phenylsulfonyl)-[1,2,3]triazolo[1,5A]quinazolin-5(4H)-one derivatives CUTA, OR10J3, CCR10 TRPV4 2399/4885FFAR4 2689/4885ALDH1A1 1420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.